Client brief on Monday.
Market-entry decisions by Friday.

The Challenge

A North American health marketing agency got briefed by a collagen peptide brand to lead their first expansion into Singapore, Malaysia, and Thailand.

The brief called for real decisions, backed by audience data, before anything went into production:

• Product format: sachet, capsule, or ready-to-drink. Does the answer differ by market?
• Claim language: three regulatory bodies, three different standards. What passes compliance and actually resonates with buyers?
• Segment lead: beauty and skin health, joint mobility, or sports recovery. Which audience has the lowest resistance to a new brand?
• Pricing: premium or mid-market. Is that answer consistent across all three countries?

Traditional research timelines (6 weeks, external vendors, five-figure budgets) weren't an option. The client had a hard deadline. Every decision had to land before a single manufacturer, copywriter, or media buyer got briefed.

How They Used atypica

Rachel and her team showed up with four structured briefs. Each one was a precise question the brand couldn't answer without local audience intelligence. These weren't “tell us about the market” briefs. They were more like: “given how people in Malaysia actually use supplements day-to-day, which format wins, and why does that answer change in Singapore?”

atypica built AI-modeled consumer profiles for each market and segment: nine profiles total, grounded in real behavioral and attitudinal data. Everyday beauty buyers who grab supplements at pharmacies on the way home. Health-optimization buyers who read ingredient labels and follow clinical evidence. Wellness-curious buyers who discover products through social content and buy as gifts. Different people, different reactions to format, claims, price, and brand trust.

Then they ran each decision against those profiles:

• Format: Across all three markets, the profiles returned the same signal. Sachet fit how people actually take supplements in Southeast Asia: on commutes, at desks, shared between colleagues. Capsule tested as “medicinal” in Thailand and Malaysia, the kind of association that undermines a beauty-led entry before the product hits shelf. → Sachet confirmed as the lead SKU across all three markets before a single manufacturer conversation began.
• Claims: The agency tested multiple benefit language options against each market's profiles, then checked them against regulatory frameworks (HSA in Singapore, MOH in Malaysia, Thai FDA). “Skin from within” and “your daily collagen ritual” consistently outperformed clinical efficacy claims on resonance. Each market's compliant phrasing was confirmed before any copy went to production. → Three regulatory-cleared copy tracks, locked before production started.
• Segment: Every market came back with the same answer: beauty-led positioning had the highest purchase intent and lowest new-brand resistance. Sports recovery had a real audience in Singapore, but not enough traction in Malaysia and Thailand to lead with. → Beauty as the entry segment across all three markets; sports recovery deferred to phase two in Singapore only.
• Pricing: Singapore and Thailand held for premium. The category framing supported it, profiles confirmed it. Malaysia didn't transfer: mid-market incumbents had already set the reference price, buyers were anchored there. → A separate anchor SKU for Malaysia was designed into the launch plan before media spend was allocated.

The same nine consumer profiles were used across all four research phases. No rebuilding, no re-briefing. Each phase compounded on the last. By the time the fourth decision landed, the agency was working with three rounds of validated audience intelligence behind it.

The Results

The collagen brand launched across three markets on schedule. Format, claim language, segment lead, and pricing were all grounded in audience intelligence, confirmed before a single dollar of media was committed. The launch campaign delivered 3.4x ROAS in month one. The client's strongest new market entry performance in five years.

For the agency, the shift went beyond speed. It was the ability to walk into the strategy session with decisions already made, and defend them with evidence before the client committed a dollar.

“We used to build the research around what we could get done in time. Now we build the strategy around what the research actually tells us. That's a different kind of agency.”

— Rachel, Account Director